(Q54933469)

4

object named as

Cynthia Tallant

0 references

Christopher J. Schofield

9

object named as

Christopher J. Schofield

0 references

author name string

Duncan A. Hay

1

0 references

Catherine M. Rogers

2

0 references

Oleg Fedorov

3

0 references

Sarah Martin

5

0 references

Octovia P. Monteiro

6

0 references

Stefan Knapp

8

0 references

Paul E. Brennan

Creative Commons Attribution 3.0 Unported

10

0 references

publication date

2015

0 references

published in

MedChemComm

0 references

volume

6

0 references

issue

7

0 references

page(s)

1381-1386

0 references

copyright license

start time

11 August 2015

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Histone recognition and large-scale structural analysis of the human bromodomain family

1 reference

https://api.crossref.org/works/10.1039%2FC5MD00152H

Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5MD00152H

BRD7, a novel PBAF-specific SWI/SNF subunit, is required for target gene activation and repression in embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5MD00152H

Bromodomain protein 7 interacts with PRMT5 and PRC2, and is involved in transcriptional repression of their target genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5MD00152H

The transcriptional regulation role of BRD7 by binding to acetylated histone through bromodomain

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5MD00152H

Gain at chromosomal region 5p15.33, containing TERT, is the most frequent genetic event in early stages of non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5MD00152H

BRD7, a novel bromodomain gene, inhibits G1-S progression by transcriptionally regulating some important molecules involved in ras/MEK/ERK and Rb/E2F pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5MD00152H

BRD7 suppresses the growth of Nasopharyngeal Carcinoma cells (HNE1) through negatively regulating beta-catenin and ERK pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5MD00152H

Polybromo-associated BRG1-associated factor components BRD7 and BAF180 are critical regulators of p53 required for induction of replicative senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5MD00152H

BRD7 is a candidate tumour suppressor gene required for p53 function

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5MD00152H

BRD7, a subunit of SWI/SNF complexes, binds directly to BRCA1 and regulates BRCA1-dependent transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5MD00152H

Prognostic relevance of BRD7 expression in colorectal carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5MD00152H

Tumor suppressive effects of bromodomain-containing protein 7 (BRD7) in epithelial ovarian carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5MD00152H

The interactions between MicroRNA-200c and BRD7 in endometrial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5MD00152H

[1,2,4]triazolo[4,3-a]phthalazines: inhibitors of diverse bromodomains

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5MD00152H

9H-purine scaffold reveals induced-fit pocket plasticity of the BRD9 bromodomain

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5MD00152H

LP99: Discovery and Synthesis of the First Selective BRD7/9 Bromodomain Inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5MD00152H

Target validation using chemical probes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5MD00152H

Fragment-based discovery of bromodomain inhibitors part 1: inhibitor binding modes and implications for lead discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5MD00152H

Discovery and Characterization of GSK2801, a Selective Chemical Probe for the Bromodomains BAZ2A and BAZ2B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5MD00152H

Bromodomain-peptide displacement assays for interactome mapping and inhibitor discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5MD00152H

Selective inhibition of BET bromodomains

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5MD00152H

The design and synthesis of 5- and 6-isoxazolylbenzimidazoles as selective inhibitors of the BET bromodomains

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5MD00152H

Discovery of a Chemical Tool Inhibitor Targeting the Bromodomains of TRIM24 and BRPF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5MD00152H

Assessing cellular efficacy of bromodomain inhibitors using fluorescence recovery after photobleaching

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5MD00152H